Search

Author/Creator Kasper, M-A

1. TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30. (September 2022)

Authors:
Gerlach, M; Schmitt, S; Cyprys, P; Kasper, M-A; Mai, I; Vermeer, MH; Horwitz, SM; Fingerle-Rowson, G; Vogl, A; Schumacher, D; Helma-Smets, J
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search